TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
ELVN

Enliven Therapeutics Inc.

Healthcare · Biotechnology

44.30$ -1.8% vs. previous close Closing price · As of: Oct 30, 2026

Ownership

Ownership Structure

Who owns Enliven Therapeutics Inc. (ELVN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 82.6% of the shares are freely tradable; institutional investors hold 89.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 89.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 6.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 82.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 20.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 73Mio.

Largest Shareholders

Institutions

Institutions ELVN
Name Stake (%) Shares Change (%) Date
FMR Inc 13.68 10,025,017 +46.8 06/30/2026
Orbimed Advisors LLC 9.25 6,776,632 -14.9 06/30/2026
Polar Capital Holdings PLC 8.78 6,430,636 +26.9 06/30/2026
BlackRock Inc 5.95 4,359,704 +18.3 06/30/2026
Vestal Point Capital LP 5.46 4,000,000 +23.1 06/30/2026
COMMODORE CAPITAL LP 4.47 3,275,000 +0.0 06/30/2026
T. Rowe Price Associates, Inc. 3.96 2,903,907 +2,870.8 06/30/2026
Vanguard Capital Management, LLC 3.51 2,569,002 +18.5 06/30/2026

Funds

Funds ELVN
Name Stake (%) Shares Change (%) Date
Polar Capital Healthcare Opports Inc 4.93 3,610,672 +0.0 08/31/2026
Polar Capital Biotech S Inc 3.49 2,555,889 +0.0 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings ELVN
Person Role Shares Value As of Type
Kunkel Lori Anne Director 41,884 1,855,461 $ Jul 6, 2026 direct
Hohl Benjamin CHIEF FINANCIAL OFFICER 38,000 1,683,400 $ Oct 19, 2026 direct
Collins Helen Louise CHIEF MEDICAL OFFICER 25,000 1,107,500 $ Oct 19, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Oct 19, 2026 Hohl Benjamin CHIEF FINANCIAL OFFICER Sell 6,018 38.48 231,546
Oct 19, 2026 Hohl Benjamin CHIEF FINANCIAL OFFICER Other 6,018 14.85 89,367
Oct 19, 2026 Collins Helen Louise CHIEF MEDICAL OFFICER Sell 5,000 38.47 192,342
Oct 19, 2026 Collins Helen Louise CHIEF MEDICAL OFFICER Other 5,000 2.48 12,400
Oct 1, 2026 Garland J. Scott Director Sell 13,000 46.67 606,719
Oct 1, 2026 Garland J. Scott Director Other 13,000 15.47 201,110
Sep 17, 2026 Hohl Benjamin CHIEF FINANCIAL OFFICER Sell 289 51.49 14,881
Sep 17, 2026 Hohl Benjamin CHIEF FINANCIAL OFFICER Sell 2,194 50.72 111,270
Sep 17, 2026 Hohl Benjamin CHIEF FINANCIAL OFFICER Sell 3,535 50.03 176,851
Sep 17, 2026 Hohl Benjamin CHIEF FINANCIAL OFFICER Other 3,982 14.85 59,133
Sep 17, 2026 Collins Helen Louise CHIEF MEDICAL OFFICER Sell 240 51.48 12,356
Sep 17, 2026 Collins Helen Louise CHIEF MEDICAL OFFICER Sell 1,844 50.71 93,507
Sep 17, 2026 Collins Helen Louise CHIEF MEDICAL OFFICER Sell 2,916 50.03 145,891
Sep 17, 2026 Collins Helen Louise CHIEF MEDICAL OFFICER Other 5,000 2.48 12,400
Aug 17, 2026 Hohl Benjamin CHIEF FINANCIAL OFFICER Sell 1,388 59.35 82,383
Aug 17, 2026 Hohl Benjamin CHIEF FINANCIAL OFFICER Sell 4,630 58.35 270,168
Aug 17, 2026 Collins Helen Louise CHIEF MEDICAL OFFICER Sell 1,100 59.35 65,281
Aug 17, 2026 Collins Helen Louise CHIEF MEDICAL OFFICER Sell 3,900 58.37 227,650
Aug 17, 2026 Collins Helen Louise CHIEF MEDICAL OFFICER Other 5,000 2.48 12,400
Aug 4, 2026 Derynck Mika K Director Sell 158,795 60.21 9,561,587
Aug 4, 2026 Derynck Mika K Director Other 20,491 22.47 460,433
Aug 4, 2026 Derynck Mika K Director Other 23,364 14.85 346,955
Aug 4, 2026 Derynck Mika K Director Other 27,567 25.28 696,894
Aug 4, 2026 Derynck Mika K Director Other 87,373 2.48 216,685
Jul 17, 2026 Hohl Benjamin CHIEF FINANCIAL OFFICER Sell 123 53.87 6,626
Jul 17, 2026 Hohl Benjamin CHIEF FINANCIAL OFFICER Sell 2,638 53.38 140,823
Jul 17, 2026 Hohl Benjamin CHIEF FINANCIAL OFFICER Sell 2,564 52.32 134,143
Jul 17, 2026 Hohl Benjamin CHIEF FINANCIAL OFFICER Sell 369 51.48 18,997
Jul 17, 2026 Hohl Benjamin CHIEF FINANCIAL OFFICER Sell 324 49.97 16,191
Jul 17, 2026 Hohl Benjamin CHIEF FINANCIAL OFFICER Other 1,072 2.48 2,659
Jul 17, 2026 Collins Helen Louise CHIEF MEDICAL OFFICER Sell 63 53.92 3,397
Jul 17, 2026 Collins Helen Louise CHIEF MEDICAL OFFICER Sell 2,184 53.42 116,669
Jul 17, 2026 Collins Helen Louise CHIEF MEDICAL OFFICER Sell 2,063 52.39 108,085
Jul 17, 2026 Collins Helen Louise CHIEF MEDICAL OFFICER Sell 459 51.55 23,660
Jul 17, 2026 Collins Helen Louise CHIEF MEDICAL OFFICER Sell 231 50.05 11,563
Jul 17, 2026 Collins Helen Louise CHIEF MEDICAL OFFICER Other 5,000 2.48 12,400
Jul 6, 2026 Kunkel Lori Anne Director Sell 5,889 50.84 299,421
Jul 6, 2026 Kunkel Lori Anne Director Sell 4,111 49.98 205,482

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?